• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老药和先导药物的新视野。

New horizons for old drugs and drug leads.

机构信息

Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory , P.O. Box B, Frederick, Maryland 21702, United States.

出版信息

J Nat Prod. 2014 Mar 28;77(3):703-23. doi: 10.1021/np5000796. Epub 2014 Feb 5.

DOI:10.1021/np5000796
PMID:24499205
Abstract

There is mounting urgency to find new drugs for the treatment of serious infectious diseases and cancer that are rapidly developing resistance to previously effective drugs. One approach to addressing this need is through drug repurposing, which refers to the discovery of new useful activities for "old" clinically used drugs through screening them against relevant disease targets. A large number of potential drug that, for various reasons, have failed to advance to clinical and commercial use can be added to the candidates available for such purposes. The application of new techniques and methodology developed through the impressive progress made in multidisciplinary, natural product-related research in recent years should aid substantially in expediting the discovery and development process. This review briefly outlines some of these developments as applied to a number of selected natural product examples, which may also include advances in chemical synthesis of derivatives with extended biological activities.

摘要

对于迅速产生抗药性的严重传染病和癌症,人们迫切需要寻找新的治疗药物。解决这一需求的一种方法是重新利用药物,即通过针对相关疾病靶点对“老”临床用药进行筛选,发现其新的有用活性。由于各种原因未能进入临床和商业应用的大量潜在药物,可以作为候选药物加入到这类药物中。近年来,多学科、天然产物相关研究取得了令人瞩目的进展,其中开发的新技术和方法应该可以大大加快发现和开发过程。本文简要概述了这些进展在一些选定的天然产物实例中的应用,其中还可能包括具有扩展生物活性的衍生物的化学合成方面的进展。

相似文献

1
New horizons for old drugs and drug leads.老药和先导药物的新视野。
J Nat Prod. 2014 Mar 28;77(3):703-23. doi: 10.1021/np5000796. Epub 2014 Feb 5.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
[Chemical study on bioactive natural products of novel structural types].[新型结构类型生物活性天然产物的化学研究]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Aug;26(4):347-50.
4
Recent developments in research on terrestrial plants used for the treatment of malaria.关于用于治疗疟疾的陆生植物的研究的最新进展。
Nat Prod Rep. 2010 Jul;27(7):961-8. doi: 10.1039/c002196m. Epub 2010 Jun 8.
5
Recent advances in natural products from plants for treatment of liver diseases.植物来源天然产物治疗肝脏疾病的最新进展。
Eur J Med Chem. 2013 May;63:570-7. doi: 10.1016/j.ejmech.2012.12.062. Epub 2013 Mar 4.
6
Current developments in the discovery and design of new drug candidates from plant natural product leads.从植物天然产物先导物中发现和设计新候选药物的当前进展。
J Nat Prod. 2004 Feb;67(2):273-83. doi: 10.1021/np030373o.
7
Phytochemistry and pharmacognosy.植物化学与生药学。
Phytochemistry. 2007 Nov-Dec;68(22-24):2960-72. doi: 10.1016/j.phytochem.2007.06.028. Epub 2007 Aug 29.
8
Natural products as drug leads: an old process or the new hope for drug discovery?天然产物作为药物先导物:是一种古老的方法还是药物研发的新希望?
IDrugs. 2005 Dec;8(12):990-2.
9
Uncovering the therapeutic potential of natural products with biomarker-guided screening.通过生物标志物引导的筛选揭示天然产物的治疗潜力。
IDrugs. 2010 May;13(5):321-4.
10
Rational approaches to natural-product-based drug design.基于天然产物的药物设计的合理方法。
Curr Opin Drug Discov Devel. 2006 Jul;9(4):445-62.

引用本文的文献

1
Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4.二甲双胍通过靶向成纤维细胞生长因子受体4(FGFR4)使三阴性乳腺癌对组蛋白去乙酰化酶抑制剂敏感。
J Biomed Sci. 2025 Mar 17;32(1):36. doi: 10.1186/s12929-025-01129-7.
2
Exploring the potential antimalarial properties, safety profile, and phytochemical composition of Mesua ferrea Linn.探索铁力木的潜在抗疟特性、安全性概况及植物化学成分。
PLoS One. 2024 Dec 2;19(12):e0312047. doi: 10.1371/journal.pone.0312047. eCollection 2024.
3
In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer.
针对癌症特征的天然产物的体内和临床研究。
Handb Exp Pharmacol. 2025;287:95-121. doi: 10.1007/164_2024_716.
4
Antitumoral Activity of Cecropia Pachystachya Leaves Extract in Vitro and in Vivo Model of Rat Glioma: Brain and Blood Effects.赛洛皮娅叶提取物的体外抗肿瘤活性及体内大鼠神经胶质瘤模型的脑血效应。
Mol Neurobiol. 2024 Oct;61(10):8234-8252. doi: 10.1007/s12035-024-04086-8. Epub 2024 Mar 14.
5
Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives.桦木酸治疗脑胶质瘤:现状、挑战与展望。
Int J Mol Sci. 2024 Feb 9;25(4):2108. doi: 10.3390/ijms25042108.
6
Regulatory Effect of Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis.乳胶对人乳头瘤病毒阳性宫颈癌细胞系细胞周期进程的调节作用:来自基因表达分析的见解
Pharmaceuticals (Basel). 2023 Dec 12;16(12):1723. doi: 10.3390/ph16121723.
7
Latex Modulates Immunity-Linked Gene Expression in Human Papillomavirus Positive Cervical Cancer Cell Lines: Evidence from RNA Seq Transcriptome Analysis.乳胶调节人乳头瘤病毒阳性宫颈癌细胞系中的免疫相关基因表达:来自 RNA 测序转录组分析的证据。
Int J Mol Sci. 2023 Sep 4;24(17):13646. doi: 10.3390/ijms241713646.
8
Plant cultures: A promising and emerging technology for the feasible production of antidiabetic metabolites in .植物培养:可行的生产抗糖尿病代谢物的有前途和新兴技术。
Front Endocrinol (Lausanne). 2022 Dec 19;13:1029942. doi: 10.3389/fendo.2022.1029942. eCollection 2022.
9
In silico analyses of betulin: DFT studies, corrosion inhibition properties, ADMET prediction, and molecular docking with a series of SARS-CoV-2 and monkeypox proteins.桦木醇的计算机模拟分析:密度泛函理论研究、缓蚀性能、ADMET预测以及与一系列新冠病毒和猴痘病毒蛋白的分子对接
Struct Chem. 2022 Oct 27:1-12. doi: 10.1007/s11224-022-02079-8.
10
Sesquiterpenoids from the Mangrove-Derived 094102.来自红树林的倍半萜类化合物 094102。
Mar Drugs. 2022 Jun 22;20(7):408. doi: 10.3390/md20070408.